Comments on: “Dose Dense” Administration of Paclitaxel and Carboplatin Increases Progression Free and Overall Survival in Ovarian Cancer Patients – Is There a New Standard of Care? http://healthinfoispower.wordpress.com/2008/06/25/dose-dense-administration-of-paclitaxel-and-carboplatin-increases-progression-free-and-overall-survival-in-ovarian-cancer-patients-is-there-a-new-standard-of-care/ *Helping*Ovarian Cancer Survivors*Persevere Through*Education Fri, 13 Nov 2009 23:21:02 +0000 http://wordpress.com/ hourly 1 By: Paul Cacciatore http://healthinfoispower.wordpress.com/2008/06/25/dose-dense-administration-of-paclitaxel-and-carboplatin-increases-progression-free-and-overall-survival-in-ovarian-cancer-patients-is-there-a-new-standard-of-care/#comment-155 Paul Cacciatore Mon, 13 Oct 2008 15:22:11 +0000 http://healthinfoispower.wordpress.com/?p=191#comment-155 Dear Mary, Thank you for the comment. I will try to determine which drug was given first, and more importantly, whether the drug administration order carries significance. I thought that paclitaxel is generally administered first under the general standard of care, but the answer to your question is best directed to Dr. Isonishi. Did you review the full article text? You should be able to obtain a copy of the full text article from an oncologist that you work with or through the medical research staff who work at your facility. If the article does not provide the answer, you could send an email to the study team member listed as the contact person in the full text article. Also, the ASCO website provides a video presentation with respect to Abstract 5506, but it may not provide an answer to your question. I trust this information is helpful. Best, Paul Dear Mary,

Thank you for the comment. I will try to determine which drug was given first, and more importantly, whether the drug administration order carries significance. I thought that paclitaxel is generally administered first under the general standard of care, but the answer to your question is best directed to Dr. Isonishi. Did you review the full article text? You should be able to obtain a copy of the full text article from an oncologist that you work with or through the medical research staff who work at your facility. If the article does not provide the answer, you could send an email to the study team member listed as the contact person in the full text article. Also, the ASCO website provides a video presentation with respect to Abstract 5506, but it may not provide an answer to your question.

I trust this information is helpful.

Best,

Paul

]]> By: Mary E. Turchi, RN, BSN, OCN http://healthinfoispower.wordpress.com/2008/06/25/dose-dense-administration-of-paclitaxel-and-carboplatin-increases-progression-free-and-overall-survival-in-ovarian-cancer-patients-is-there-a-new-standard-of-care/#comment-154 Mary E. Turchi, RN, BSN, OCN Fri, 10 Oct 2008 19:17:56 +0000 http://healthinfoispower.wordpress.com/?p=191#comment-154 Did you give the carbo or taxol first. Does it matter? Thank you. Did you give the carbo or taxol first.
Does it matter?

Thank you.

]]>